A research project funded by The Horse Trust has found that various types of ocular tumours can be successfully treated with mitomycin C, a cytotoxic antibiotic isolated from a bacterium.
The research concludes that mitomycin C offers a safe and cost effective alternative to current treatment options such as surgery and radiation.
The research project was led by Fernando Malalana, while working as The Horse Trust's Clinical Scholar in Equine Internal Medicine at University of Liverpool. Fernando is now working as a Clinician Teacher in Equine Internal Medicine at the university.
Ocular tumours are more difficult to treat than tumours in other parts of the horse's body due to the risk of damaging the eye. In the study, Malalana investigated the use of mitomycin C in treating ocular squamous cell carcinoma, the most common ocular tumour in horses, and occular sarcoids, skin tumors that frequently affect the eyelids .
Mitomycin C is an antibiotic isolated from a bacterium, Streptomyces caespitosus. It is known to have cytotoxic effects and has been used to treat tumours in horses before, but only in combination with surgery.
Currently, the main method of treating ocular squamous cell carcinoma is by removing the tumour surgically or with radiation. Both treatments are costly and have a number of associated risks. There is also the risk of damage or scarring to the eye.
Fourteen horses with ocular squamous cell carcinoma, three of which were affected bilaterally, were included in the study. Mitomycin C was applied to the conjunctival sac of the affected eye; in some of the cases the treatment was combined with surgery. Malalana found that of the 8 eyes treated with mitomycin C alone, clinical resolution occurred in 6 cases. Of the 9 eyes treated with both surgery and mitomycin C, clinical resolution occurred in 7 cases.
Mitomycin C was also used to treat various types of sarcoids found in the eye. Currently, the most effective treatment for occular sarcoids is radioactive wire. However, radioactive wire treatment is not ideal as it is expensive, only offered in two locations in the UK, and has potential health risks to the vet applying the wire due to exposure to radioactivity.
Six horses and two donkeys with occular sarcoids, including one horse that was affected bilaterally, were treated with mitomycin C, which was injected directly into the tumour. Malalana found that of the nine nodular and fibroplastic occular sarcoids treated with the antibiotic, all were completely cleared. However, the vets did not have good results with verrucous sarcoids.
Malalana said: "The results of this research should offer hope to the owners of horses that have eye tumours. We have already been contacted by vets from across Europe to find out more information about this treatment and hope that it will be offered to more horses with occular tumours in the future".
Vets at the University of Liverpool are now testing the use of mitomycin C on other tumours that are difficult to treat surgically, including melanomas near the horse's anus. So far, two cases have been treated, but it is too early to tell whether treatment has been successful.
Malalana's research has been submitted to Veterinary Ophthalmology journal.
Her Royal Highness Princess Anne has opened the Royal Veterinary College's new Teaching and Research Centre.
The Centre - at the college's Hawkshead Campus in Potters Bar, Hertfordshire - will provide a home for the RVC's lifestyle research, which includes conditions such as obesity/diabetes, chronic kidney disease and arthritis as well as those with genetic roots.
RVC Principal Professor Stuart Reid said: "The RVC is extremely proud to have welcomed Her Royal Highness to open the new Teaching and Research Centre - a facility where our students are taught within an environment that is all about advanced scientific discovery and first class research. The building houses the engine of academic enquiry and is a wonderful space where our academic community generates new insights into diseases that affect humans and animals.
"The Centre allows us to tie together the various threads we have around the study of illnesses that result from lifestyle in humans and animals, such as those associated with age or genetic disorders. Our College collaborates with the research hub that is the London scientific research community. We are extremely well placed to carry out the work in conjunction with human medical research groups and bring the veterinary perspective to the understanding of disease. The building offers new opportunities, both nationally and internationally".
Funding for the building of the new centre was provided by HEFCE and The Wolfson Foundation.
Photo: Paul West
Companion Care Vets has opened its first new standalone joint venture surgery in Ayr, Scotland.
At 3,071 sq ft the £300,000 surgery is the largest of the groups' 86 strong network and is the first standalone surgery to be opened under the joint venture partnership model that has been in place since 2001.
The surgery is located in a retail park environment, to give easy access for clients and their pets. It is a full service practice, which Companion Care says is fitted with all the latest equipment, including digital x-ray machines and a full operating suite.
Managing Director, Jane Balmain, said: "The opening of our first new standalone surgery in Ayr is a real milestone for us as a business because it opens up our offering to the vets and veterinary nurses who are interested in a joint venture partnership, but whose preference is to have a more traditional looking standalone surgery."
Whilst the Ayr surgery is standalone in its own right, due to the unique relationship Companion Care Vets has with Pets at Home, the surgery works in close partnership with the local Pets at Home store. This will help to drive client registrations and business development and further enable Pets at Home to develop the full pet care experience for its customers.
Jane added: "We believe that this new venture offers any potential partner the best of both worlds: a superb in-store surgery with footfall of thousands of customers a month, or a standalone new surgery linked to local store network to develop the business. I don't believe any other company can offer this unique proposition."
Veterinary surgeon, and joint venture partner of the Ayr surgery, Kirstin Fyfe says, "I am extremely proud to be opening the first standalone surgery alongside the Companion Care team and the facilities available to my team and I and local pet owners are fantastic. The latest equipment, coupled with a spacious and modern waiting area and the convenience of our location is what makes this a winning formula."
The Royal College of Veterinary Surgeons has produced bookmarks for accredited practices to give clients, which explain the RCVS Practice Standards Scheme (PSS).
Lizzie Lockett, Head of the RCVS Communications Department said: "A key part of the PSS is helping practices explain their accreditation to clients - and the bookmarks are a simple and eye-catching promotional tool for this. We hope they will have the advantage over conventional leaflets of being kept, and used, by clients, meaning the accredited-practice message is more likely to be taken on board. Although many people are using e-books these days, the traditional book - and bookmark - still has a place."
All accredited practices may order a free sample of 100 bookmarks, and a further 400 free bookmarks are available to practices recently renewing or receiving accreditation. More bookmarks may also be ordered from the RCVS, as well as the new accredited-practice logos. To find out more, or download an order form, practices can visit www.rcvs.org.uk/PSSpromo.
Animalcare has been found in breach of Clause 18.2 of the NOAH Code of Practice for offering and supplying infusion pumps/equipment in exchange for veterinary practices entering into written contracts for the purchase of a range of its products, including the POM-V Benazecare.
The value of the equipment offered by Animalcare equated with a discount agreed with the veterinary practice, and was applied as medicinal products were purchased. The equipment was supplied on the signing of a contract. The terms of the contract required a particular quantity of medicinal products to be purchased, and if the veterinary practice failed to meet that requirement, there was a liability to pay a pro-rata element of the equipment purchase price.
The Code of Practice Committee was of the view that a piece of equipment was neither 'price' nor 'product' within the meaning of Clause 18.2 of the Code of Practice; and as such amounted to a gift being offered in relation to the sale; or purchase; or prescription of animal medicine. The Committee took into account that Guidance Note 4, paragraph 7, states that the word "gift" includes any pecuniary advantage being offered, with the exception of price or product itself.
To comply with Code of Practice Clause 18.2, the offer or inducement based on price had to be one of cash as rebated discount. If then there were facilities to enable the veterinary practice to use that rebated discount to purchase the equipment from the supplier, that might be acceptable, but there was a necessity for cash as rebated discount to be provided in the first instance.
Full details of the Committee's rulings are available on the NOAH website at www.noah.co.uk/code.
Norbrook Laboratories has launched NoroQuin, a nutritional glucosamine-based supplement which the company claims will help maintain healthy cartilage and joint fluids in cats, dogs and horses.
The NoroQuin range has six active ingredients including glucosamine, chondroitin sulphate, manganese sulphate, zinc sulphate, absorbic acid and N-Acetyl-D-Glucosamine which combine to maintain glycosaminoglycans (GAGs) levels in joints and, according to Norbrook, ease and reduce the onset of joint damage and cartilage degeneration.
Michelle Jones, Norbrook Brand Manager, said: "Our new NoroQuin range is an exciting new development to our joint-management range.
"NoroQuin offers more ingredients than the competition with 6 active ingredients working together to help improve mobility. The main ingredient, glucosamine stimulates natural repair and prevents cartilage degeneration and thinning while it is widely considered that glucosamine and chondroitin sulphate have anti-inflammatory properties, making Noroquin ideal for assisting with pain management. The addition of manganese sulphate helps stimulate natural cartilage repair."
NoroQuin is available in a range of meat flavoured tablet sizes that have been formulated to treat all dogs from growing puppies to the largest dogs. For cats, the range is available in a tablet form or as a powder which can be added to a cat's food.
NoroQuin for dogs and cats is available to order from wholesalers now.
Vetoquinol has announced that the 50g pack size of Ipakitine will shortly be replaced by a 60g pot.
The company says this will provide the convenience of a 30 day supply for a 5kg cat or dog who is on 1g/5kg bodyweight twice a day (one level scoop twice a day).
The 60g pot will be available from the end of December. Also at this time, the existing 150g size pot will be replaced by a 180g pot.
The new packaging is more eye-catching, easier to read and gives more description. A 300g pot will also be available in February 2012. Pricing will be in-line with increase in pack size, so proportionally a 20% increase for 20% more product.
Ipakitine is a phosphate binder formulated specifically for veterinary use. It is designed for both cats and dogs and is available as a tasteless powder formulation for easy administration with food.
The London Vet Show was a runaway success this year, with more delegates on day one than visited the entire show in 2010.
Rob Chapman from CloserStill Media, organiser of the event said: "We're still number crunching, but it looks like numbers were up something like 40% on last year."
VetSurgeon.org visited the event and filmed a number of the commercial exhibitors, many of whom said what a good atmosphere there was at the show and how busy it was.
CloserStill has already confirmed that the London Vet Show will again take place in the Grand Hall at London Olympia next year. However, it will be expanding into West Hall for the clinical lectures, so that everyone can have a seat, unlike this year when demand was so high, some had to sit on the floor.
The BSAVA has announced a partnership with the University of Liverpool to develop a national UK disease surveillance network for companion animals.
Originally established in 2008, the Small Animal Veterinary Surveillance Network, SAVSNET, aimed to monitor the disease status of the UK small animal population (mainly dog, cat and rabbit). However, funding for the project came to an end in August 2011. At this point, BSAVA stepped in with support, as it believed that not only would the profession benefit from this source of information, but that it is in fact vital for the successful management of disease in small animals.
BSAVA President Andrew Ash said: "SAVSNET ticks all the boxes for BSAVA. High quality large scale epidemiological research helps us fulfil our obligations as a charity to public good, the information on disease surveillance gives us the information to treat animals better, and the research papers help us inform veterinary policy and education. This is an important scheme for both animal and human health."
Participation by diagnostic labs and practices is voluntary, and all data gained will be made anonymous before being reported. For more information, email savsnet@liverpool.ac.uk.
Dunlops has changed its name to Henry Schein Animal Health.
David Hinton, Managing Director said: "As we change our name to Henry Schein Animal Health, we also reaffirm our company's strong commitment to offer a comprehensive array of products and services to help animal health practitioners in the United Kingdom operate more efficient and successful practices, and provide the best quality patient care.
"We have a new name, but we have the same strong team, the same values, and the same dedication to providing excellent service to our customers."
Henry Schein Animal Health’s expanded offerings include VetLink and Thrive. VetLink is a new e-commerce web site system that enables veterinary surgeons to access the growing internet sector, allowing you to sell anything from pet prescriptions to accessories online, to be delivered to your customers’ homes by Henry Schein Animal Health. Thrive is a new veterinary business analysis service that integrates with practice management software to use a Key Performance Indicator based approach that provides insight into a your practice and identifies areas where you can enhance your business.
Avid has released a new version of it's microchip registration system, which offers a significantly enhanced statistical analysis of the microchipping done at your practice.
The new MicroChip Plus section of the site is specifically for implanters, and contains the following:
Avid says the registration system, which has built-in postcode software, can now re-use more registration details, so that registering a complete litter will take less time. This is especially important when microchips are being registered for or by breeders.
Denise Chaloner, Manager at Avid said: “Avid MicroChip Plus gives our customers more control of how they manage pet microchipping within their organisation. Listening to feedback has inspired Avid to develop a more tailor-made and efficient system for the end user, also enabling the generation of reports, statistics and targets”.
Customers with supporting practice management systems may register microchips directly from their software using VetXML and VetEnvoy.
For more information contact Avid on freephone 0800 652 7 977 or email sales@avidplc.com
Nutricat, a supermarket cat food launched this year, has released the results of a survey which, it says, shows that modern day lifestyles are resulting in British cat owners anthropomorphising their cats.
The survey found that 54% of cat owners believe their cat shares similar emotions to them, 40% sign greetings cards from their cat, and 1/3 say their cat is a better listener than their partner.
Anthropomorphism is nothing new, and since the press release came from a supermarket brand, it would ordinarily have been destined for the 'Deleted Items' folder.
However, one thing caught my eye. In the press release, Nutricat was described as: a new brand of veterinarian approved advanced feline nutrition'.
But it's not just how Nutricat is described in the press release. The title of the Nutricat website is: 'Veterinarian approved cat food', and the words 'veterinarian approved' appear no less than 3 times on the home page. It doesn't stop there. Tesco seems to have got the message too.
So how many veterinary surgeons are required to endorse something in order to claim, reasonably, that it is 'veterinarian approved'. A couple of RCVS Specialists in Feline Medicine? 10 general practitioners? 20? 50? 100?
VetSurgeon.org rang the PR agency for Nutricat and asked the question.
The answer is one.
What do you think? Take part in our poll, here: http://www.vetsurgeon.org/forums/t/9928.aspx
The British Veterinary Association has welcomed the European Commission's Action Plan on Antimicrobial resistance (AMR), launched yesterday on the eve of European Antibiotic Awareness Day.
The Action Plan sets out 12 actions:
However, the association has expressed concern that the Commission has given only qualified support for new antimicrobials for veterinary use. Carl Padgett, President of the BVA, said: "There is much to be applauded in this action plan. In particular the BVA supports the calls for more and better coordinated research, more responsible use of antimicrobials in human and veterinary medicine, and the development of diagnostic tools to quickly and accurately identify the right drug for the right bug.
"The use of antimicrobials in the treatment and control of animal diseases is essential and the BVA supports the strong messages in this plan. Any option for managing AMR must be firmly rooted in sound scientific assessment of the risk.
"While the report recognises the difficulties that have led to the hampering of research into new antimicrobials for veterinary use, we are concerned that there is only qualified support from the Commission for the development of these new medicines for animal use.
"Research into new antimicrobials should be supported in both human and veterinary medicine. We need to ensure the creation of a more predictable regulatory environment to encourage new products for animals to be brought to the market.
"Finally, while the BVA supports the need for a new regulatory framework any new regulations must not impede the ability of veterinary surgeons to prescribe and dispense medicines according to their clinical judgement."
Meanwhile, Jill Moss of the Bella Moss Foundation added her voice to those calling for responsible use of antibiotics, highlighting recent research from the Royal Veterinary College that has established a clear link between pets with MRSA infection and human hospital-associated MRSA. What is less widely recognised, she says, is that resistant bacteria can be passed from human to animal.
The charity is now calling on health and veterinary professionals to work together to achieve a reduction in resistant infections by raising awareness and promoting the responsible use of antibiotics.
The Royal College of Veterinary Surgeons is calling for comment on a draft Performance Protocol, which aims to manage proportionately any justified concerns about the professional performance of veterinary surgeons and registered veterinary nurses.
The RCVS's Preliminary Investigation and Advisory Committees have been working together to develop a new protocol setting out the way in which the College will respond to ongoing performance-related concerns. There is an expectation that veterinary surgeons and RVNs are already regularly reviewing their clinical work in the workplace. This will be reinforced by the new principles-based Code of Professional Conduct, currently being finalised, which is likely to require clinical governance to be part of professional practice for veterinary surgeons and RVNs.
According to the College, the draft protocol is intended to formalise and build on the way it already manages ongoing serious performance-related concerns. It introduces new measures, including supervision and undertakings, to seek to ensure that veterinary surgeons and RVNs take reasonable steps to address any serious performance concerns. This will bring the RCVS into line with other professional regulators and enable a tailored and proportionate response to these cases to protect the welfare of animals and the public interest. The College's current system of offering advice to veterinary surgeons and RVNs will remain for complaints which are closed, because there is no indication of serious professional misconduct.
The College says that according to independent legal advice, such an approach is appropriate and necessary in order for it to fulfil its regulatory responsibilities. The draft performance protocol follows similar legal advice that supported the implementation of the RCVS Health Protocol, and both protocols clarify the College's parallel jurisdiction relating to health and performance-related issues.
RCVS President Jerry Davies said: "When veterinary surgeons and registered veterinary nurses are unable to deal with performance-related concerns, it is important that we are able to provide a supportive framework to oversee remedial steps that are designed to address those concerns and encourage professional development. This is best achieved outside a Disciplinary Committee hearing, if at all possible".
The approved draft protocol is now open for public consultation, and may be found at www.rcvs.org.uk/performance. All comments on the draft should be emailed to Simon Wiklund, Advisory Manager at s.wiklund@rcvs.org.uk by 13 January 2012, with 'Performance Protocol' added to the subject heading.
The feedback received from the consultation will be considered by the Preliminary Investigation and Advisory Committees in January 2012, before being submitted to RCVS Council for approval in March.
The College says it hopes that a performance protocol will form part of the supporting guidance to the new RCVS Codes of Professional Conduct for both veterinary surgeons and registered veterinary nurses.
A research project funded by equine charity The Horse Trust has found that 40% of horses suffered a traumatic injury within the past year.
Only 13% of injuries occurred during ridden exercise, while 62% occurred while the horse was turned out in the field.
The research, which has been accepted for publication by the Equine Veterinary Journal, was carried out by Rosie Owen, who is currently working as The Horse Trust's Clinical Scholar in Equine Orthopaedics at the University of Liverpool.
Rosie said: "This Horse Trust-funded research shows that horses get injured relatively frequently - much more often than you would expect. Interestingly, most of the injuries happen during turnout, rather than during ridden exercise."
The results were obtained through analysing the responses from 652 randomly selected horse owners from north-west England, Midlands and North Wales, all of whom had a horse aged 15 years or younger. Owners sought veterinary treatment for 47% of the injuries reported, while the remainder were treated by the owner or a friend, or required no treatment.
Rosie identified a number of factors that were associated with an increased risk of injury. For example, horses that had been owned for a shorter period of time were found to be significantly more at risk of injury. She says the increased risk may be due to aggression from other horses when a new horse is introduced to a field, but owners can take various steps to reduce the likelihood of injury: "It's worth trying to avoid regular changes in group composition. A new horse should be introduced to the group gradually, preferably by providing adjacent stabling initially. Protective boots may help as the lower limbs are most at risk of injury. Also, if possible, the other horses in the field should have their shoes taken off during the period of adjustment, so they are less able to injure the new horse."
Rosie also found that horses turned out within larger groups were at an increased risk of injury. This is probably due to there being a larger hierarchy with multiple horses competing for dominance. However, she found that the risk of injury reduced when additional feeding areas were provided in the field: "If you provide hay or haylage to horses in the field, it's worth including an additional feeding area to reduce competition for food."
Other interesting findings included the lower incidence of injury in cob and pony breeds, compared to other breeds. Horses used competitively also had a higher risk of injury, which may be due to the additional athletic demands placed on these horses, or due to the way these horses are managed. Horses trained using Parelli methods were also found to be at an increased risk of injury, but as the numbers in this group were small, more research is needed to confirm this.
Although most of the injuries recorded in the survey occurred during turnout, 11% occurred in the stable, with most of the injuries affecting the head or eye. Rosie says owners can easily reduce the risk of stable injury: "There are various simple steps that owners can take to reduce the risk of injury in the stable. Try to provide hay from the floor, instead of in a hay rack, and make sure there are no protruding nails, hooks or sharp edges in the stable."
Rosie said that it would be useful to conduct further research to understand how injuries occur during turnout: "A lot of injuries are reported during turnout, but we're uncertain about what happened. It would be useful to observe the behaviour of horses in the field to see whether it's competition for food, or another factor, that is responsible for the high rate of injuries among horses."
Jeanette Allen, Chief Executive of The Horse Trust, said: "We are pleased that the research we've funded has provided such useful statistics on the risks of injury for horses. We hope that horse owners will follow some of the tips that Rosie has suggested to reduce the risk of their horse being injured."
B&W Equine Group has opened a brand new, state-of-the-art equine clinic at Breadstone in Gloucestershire.
The new facility opened on 1 October 2011. It cost over £2.2 million and is, according to the company, one Europe’s most advanced diagnostic and surgical centres.
B&W Equine Group was created in 2008, following a merger between Willesley Equine Clinic and Bushy Equine Vets. The 23 vet practice has four local equine clinics in Breadstone, Cardiff, Failand and Willesley.
The new clinic, located on a four acre site at Breadstone, close to the M4 and M5 intersections, provides state-of-the-art diagnostics and advanced laboratory facilities. It houses the only equine MRI scanner in Wales and the South West, as well as a CT scanner and scintigraphy unit. Orthopaedic and colic theatres, adult and neonatal intensive care suites and separate isolation units have all been custom-designed and are supported by five examination rooms and two knock down boxes.
Clinical and referral services are led by RCVS and European Recognised Specialists in surgery, orthopaedics, diagnostic imaging and internal medicine and include gynaecological management of breeding mares and pre-season disease screening. The on-site laboratory is one of only 30 in the UK to be certified by the HBLB to test for CEM and EVA.
Ian Camm, BVSc CertEP MRCVS, Group Director, said: “We are all extremely excited about the new clinic but our day-to-day first opinion work remains a top priority. For all our local clients it’s very much a case of business as usual but the fact that we have invested in the latest portable equipment, including video endoscopes, digital radiography and ultrasound scanners, means we can undertake more specialist work at client’s yards, as and when needed.”
For further information, visit www.bwequinevets.co.uk.
Mars Veterinary is launching the Wisdom Panel Insights mixed breed dog DNA test at the Kennel Club's Discover Dogs event this weekend.
According to the company, more than 2 million dogs in the UK are mixed breed, and it is likely that many owners are unsure of their pet's parentage.
Now, with the swipe of a cheek swab, Wisdom Panel Insights can determine the ancestry of a mixed breed dog by testing for more than 185 breeds, which Mars Veterinary says is the largest database of any canine DNA test on the market. Within three weeks, dog owners are emailed an official Ancestry Report that reveals the dog's genetic background. This, it is claimed, will help owners provide better training, nutrition and exercise for their pet, and will also alert them to any disease predisposition their dog may have.
The test will be on sale for the first time at Discover Dogs at Earl's Court, and from the website: www.wisdompanel.co.uk. It costs £59.99 inc. vat, discounted for Kennel Club registered dogs.
Caroline Kisko, Secretary of the Kennel Club, said: "A dog's ancestry can influence him in surprising ways. Obvious and not-so-obvious physical traits plus behaviours like digging, herding and barking all come from the various breeds in a dog's family tree. Once an owner understands a dog's natural tendencies, it makes it possible to create a tailored training, exercise and nutrition program to fit his one-of-a-kind needs. This is one of many innovative products that dog owners and lovers will find at Discover Dogs this weekend."
Veterinary surgeons and veterinary nurses will be able to try their hands at the Royal College of Veterinary Surgeons code-cracking competition at the London Vet Show at Olympia on 24-25 November.
At the RCVS breakfast session on the Friday morning (8.30, part of the Business Stream), President Dr Jerry Davies will unlock the secrets of the proposed new Codes of Professional Conduct for vets and VNs.
To promote this breakfast session, the RCVS is inviting visitors to come to its stand (J90) to solve photo enigmas, using clues provided to decipher a series of words that appear in the proposed new Codes. The winner will be in line to receive a pair of super sleuthing video glasses.
VNs who missed BVNA Congress can also get their hands on a 50th anniversary commemorative chocolate medallion by visiting the RCVS stand.
Coffee and pastries will be served at the morning session on Friday - there's no need to book, just turn up.
Nominations are now open for candidates wishing to stand in the 2012 RCVS Council and RCVS Veterinary Nurses Council elections.
Jane Hern, RCVS Registrar said: "The veterinary surgeons and veterinary nurses that sit on the RCVS and VN Councils are vital to the governance of their professions, and in steering the activities the College undertakes under its Royal Charter. If you're interested in making sure that your profession is well-governed, its standards are upheld, and the interests of animals and the public are protected, why not consider standing in these elections?"
Six seats on RCVS Council and two on VN Council are due to be filled in the 2012 elections. Those elected will take their seats on RCVS Day next July, to serve four-year terms, and will be expected to spend at least six to eight days a year attending Council meetings, working parties and subcommittees (a loss-of-earnings allowance is available).
All prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, manifesto and photograph for inclusion in the RCVS News Extra election specials. Nobody may nominate more than one candidate, and no current member of the RCVS Council or VN Council may make a nomination.
Nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2012. Full details and guidance notes for both elections will be available on the RCVS website shortly on the RCVS Council Election page and VN Council Election page.
Nomination forms and candidate information forms for RCVS Council may be requested from Mrs Gabi Braun (020 7222 0761 or executiveoffice@rcvs.org.uk) and those for VN Council from Mrs Annette Amato (020 7202 0713 or a.amato@rcvs.org.uk).
Invicta Animal Health has announced its appointment as exclusive veterinary distributor in the UK for Chloraprep, a licensed human product for cutaneous antisepsis, prior to invasive procedures.
Invicta says Chloraprep is a single use, easy to apply, sterile system, available in a variety of sizes and in clear and tinted versions to enhance the visibility of the area requiring antisepsis, for instance, prior to surgery.
The sterile solution is maintained in a glass ampoule inside a protective outer case and, to prevent contamination, the patented design ensures users don't come into contact with either the contents or the patient's skin.
Rob Watkins, Managing Director of Invicta, said: "Most surgical site infections (SSI's) are the result of contamination from a patient's own skin flora1, a fact which highlights the importance of thorough and effective preparation of the skin as a proactive way to minimise the incidence of SSI's in patients."
According to the company, research has shown that Chloraprep, which contains 2% chlorhexidine and 70% isopropyl alcohol, has demonstrated significantly better antimicrobial activity than other combinations2.
Invicta says the way in which the solution is applied to the skin is as important as the solution itself. Studies show that the most effective way to apply Chloraprep is with a back and forth scrubbing movement because this gives a lower microbial count on the skin than using other application methods3. Once applied, Chloraprep is active in 30 seconds and is effective for up to 48 hours4.
Rob said: "The majority of UK hospitals and the Blood Transfusion Service already use Chloraprep and we are pleased to make this available under the provisions of the cascade."
He added: 'The veterinary nurses I've spoken to love this product, because they're fed up of immersing their dry, cracked hands in disinfectant!'
For further information, please contact Invicta Animal Health on 01403 791313 or email the company at mail@invictavet.com.
References
1. Florman S, Nichols RL. Am J Infect Dis 2007; 3: 51-61.2. Hibbard JS. J Infus Nurs 2005; 28: 194-207.3. Rosenthal K. Nurs Manage 2006; April: 55-66.4. Garcia R et al. Abstracts of the IDSA 40th Annual Meeting 2002; Abs 418.
Dogs Trust, the UK's largest dog welfare charity, has teamed up with leading cardiac rehabilitation experts at Harefield Hospital to help patients in their final phase of coronary recovery.
The recovery programme, Hounds Help Hearts, is, according to the charity, a UK first and encourages post coronary patients to walk dogs as part of their recovery.
The Cardiac Rehabilitation team at Harefield Hospital aims to improve the physical, social and psychological well being of people after a heart attack or similar cardiac event. Among the recommendations for an ongoing healthy lifestyle, patients are being introduced to Dogs Trust Harefield where they can help staff, canine residents and themselves by walking some of the 150 dogs in their care. The charity hopes that heart hospitals UK wide will follow suit.
Hounds Help Hearts is part of a wider initiative to promote The Dog Prescription - a research document that highlights the ways dogs can improve human health. Dogs Trust is urging GPs all over the UK to prescribe a daily dose of dog with The Dog Prescription after research highlights the health benefits of dog ownership for both children and adults.
Lynda Evans, senior nurse /modern matron at Royal Brompton & Harefield NHS Foundation Trust, said: "Walking is one of the best forms of exercise for patients recovering from a cardiac event and what better way to do it than alongside a grateful canine companion. We have been running the 'Care For Your Heart' Rehabilitation Programme for more than 20 years and as a leading specialist heart and lung hospital we are always looking for new ways to help patients to enjoy the best possible quality of life when they return home. We are delighted to be working with Dogs Trust on this initiative and partnering patients with dogs to help them reach their full potential through interaction and physical exercise."
The Dog Prescription highlights the mental and physical benefits of dog ownership and interaction and names dog ownership as an aid to the recovery of post coronary patients
Clarissa Baldwin, Dogs Trust CEO said: "We undertook this research as we were aware of the health benefits of dog ownership but wanted to fully evaluate its potential. Amongst its ten points (which are not exhaustive), the prescription details health benefits including the fact that dogs can aid the recovery of post coronary patients. We want to spread the word about the health benefits of dogs and we hope that GPs and hospitals will start to encourage patients to engage with dogs for a healthier and happier lifestyle"
You can read the full research here.
The first steps have begun to find Petplan and The Veterinary Business Journal's Practice Manager of the Year for 2012.
Nominations are now being sought for the most accomplished UK practice managers and recommendations are welcome from any member of the veterinary team.
Three finalists will be chosen and the winner announced at the annual Petplan Veterinary Awards in April 2012.
Robin Fearon, editor of the Veterinary Business Journal, said: "It is a distinct pleasure to launch the awards programme each year knowing that at the end of it we will be able to announce another winning practice manager.
"These awards are so important in promoting the role and highlighting the crucial part that managers play in practice strategy and success - we can't wait to see your nominations."
Judges will assess candidates' applications and choose the three finalists based on their competency in areas such as staff development, financial strategy and marketing initiative.
Last year's winner Denise Coston is practice manager at Castle Veterinary Surgeons in County Durham. She said: "Winning this award has meant a lot to me because it makes you feel valued. I would say to anyone thinking of nominating their practice manager: 'just do it'.
"The role of practice manager varies in each practice and can be hard to quantify with specific measures, but it means a lot to celebrate someone getting it right. It is an excellent way to promote the role of practice manager and it is great to get recognition alongside vets and nurses."
This award is supported by the Society of Practising Veterinary Surgeons and the Veterinary Practice Management Association.
As well as a plaque commemorating their achievements, the winner will once more receive one year's free membership to the VPMA.
Nominations for this year's award close on 10 February 2012. Application packs are available from: Jackie Morrison, The Veterinary Business Journal, Olympus House, Werrington Centre, Peterborough PE4 6NA, or e-mail jackiemorrison@vbd.uk.com.
Alternatively visit www.vetsonline.com/ to download yours direct.
Hertfordshire-based, multi-specialist veterinary referral centre Davies Veterinary Specialists' new pro bono scheme has saved the life of a young German shepherd dog twice in fortnight.
'Apollo' first impaled himself on some broken fence panels whilst playing. A splinter of wood, which was around 5cm long and 1.5cm wide, became lodged between his heart and lungs. However, because he initially had no symptoms and there was no obvious puncture wound, his owner Sam Russell from Leighton Buzzard wasn't aware that anything was wrong. It was a week later when the dog suddenly became very anxious, uncomfortable and was struggling to breathe, that Sam rushed him to her local vet practice, Heath and Reach in Bedfordshire.
Hannah Johnston's initial diagnosis was that the dog had some foreign material lodged internally that was causing an infection. Without an urgent CT scan and surgery his chances of survival were minimal, but his owner was uninsured and had no means of affording the treatment. Hannah had recently read about a pro bono scheme introduced by Davies Veterinary Specialists and believed that Apollo's case fitted the criteria.
She said: "It was heart wrenching to think that a young dog, with such a caring owner, was very likely to lose his life and I was determined to do anything I could to help. I couldn't help shedding a tear when DVS agreed to treat him, as I knew Apollo now had a chance. His owner had recently had an awful spate of bad luck and was so deserving of DVS's help."
Manuel Jiménez Peláez, European Veterinary Specialist in Surgery at DVS, who operated on Apollo, said: "A CT scan showed a large, fluid-filled cavity, a partially collapsed lung and a sharp, thin, elongated structure, lodged between Apollo's lungs and his heart. We drained the cavity and successfully removed the foreign body. We also had to remove most of the irreparably damaged left lung."
Apollo was in hospital for two weeks, five days of which were spent in intensive care in a critical condition. Sam was thrilled when she was eventually able to take him home, but two days later disaster struck again. Apollo was diagnosed with gastric dilation volvulus. He needed surgery within six hours to survive the condition and DVS once again stepped in to operate as an emergency, free of charge.
Apollo has made a full recovery is now back at home with the Russell family. Sam Russell said: "Apollo has always been so determined and full of life. Even when he was dangerously ill and in intensive care he wouldn't give up and tried to rouse himself to come home with me. For Davies Vet Specialists to save my dog once is nothing short of amazing but for them to save him twice makes me speechless with gratitude. To be shown such kindness after a dreadful run of bad luck would leave anyone stuck for words."
All first opinion practices are eligible to apply for the DVS pro bono scheme, which will allow an average of one patient per month to receive free treatment. Requests will be based on advocacy from the clinical head of the referring practice and on genuine need. To find out more visit http://www.vetspecialists.co.uk/ or call Dr Clive Elwood, Managing Director, on 01582 883950.
The BSAVA's Scientific Committee has issued a policy statement on the management and treatment of firework phobias in dogs.
The statement says: "It is recognised that dogs may show signs of fear or phobia of the loud noises associated with fireworks. It is the duty of veterinary surgeons to recommend and support evidence-based therapies for this noise fear or phobia in order that they may improve the welfare of animals under their care"
The statement goes on to offer recommendations and guidance for short-term management and longer-term therapy, available here.
The Registrar and Secretary of the Royal College of Veterinary Surgeons, Jane Hern, has announced that she will be standing down at the end of the year.
After 15 years in the job, Jane says she has been pleased to oversee a number of significant reforms and new initiatives in her time leading the organisation, but has decided that it is time to move on and pursue other interests.
The College says it is now embarking on a comprehensive review of its governance, committee and management structures, during which the Officers and Council will consider how best the executive should be led in future.
Jane said: "I have greatly enjoyed my time with the College and the Trust. Working with a profession held in such high regard by the public has been a real pleasure. I wish veterinary surgeons, veterinary nurses and all my colleagues all the very best for the future."
The President, Dr Jerry Davies said: "The Royal College has been very fortunate in having the benefit of Jane's wisdom and guidance for so many years, and we wish her every success in the future."